Chiao-En Wu
, M.D. (Studying Abroad)
Institution: Linkou Chang Gung Memorial Hospital
Position: Attending Physician
Department: Division of Hematology-Oncology, Department of Internal Medicine
Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-3281200 
Focus of Interest:- Oncology
Employment Records:Aug. 2007- Aug. 2012 Resident, Department of Internal Medicine, Chang Gung Memorial Hospital (CGMH)
Jul. 2010- Aug. 2012 Clinical Fellow, Division of Medical Oncology, Department of Internal Medicine, CGMH
Sep 2012-present Attending Physician, Division of Medical Oncology, Department of Internal Medicine, CGMH
Education:Chang Gung University, College of Medicine, School of Traditional Chinese Medicine, double degrees in Chinese Medicine and Medicine
Selected Publications :- Chiao-En Wu, *Chuang-Chi Liaw. Using aprepitant as secondary antiemetic prophylaxis for cancer patients with cisplatin-induced emesis. Supportive Care in Cancer. 2012, 20(10): 2357-61.
- Chiao-En Wu, Hung-Chih Hsu, Wen-Chi Shen, Yang-Chung Lin, Hung-Ming Wang, John Wen-Chen Chang, *Jen-Shi Chen. The Experience of Chemotherapy with Gemcitabine Plus Cisplatin in Patients with Advanced Biliary Tract Carcinoma in Chang Gung Memorial Hospital: A Retrospectively Analysis. Chang Gung Medical Journal 2012, 35(5): 420-7.
- Chiao-En Wu, Yung-Chang Lin, Ji-Hong Hong, Cheng-Keng Chuang, See-Tong Pang, *Chuang-Chi Liaw. Prognostic Value of Complete Response in Patients with Muscle-invasive Bladder Cancer Undergoing Concurrent Chemoradiotherapy. Anticancer Research. 2013, 33(6): 2605-2610
- Chiao-En Wu, Chia-Hsun Hsieh, Cheng-Jen Chang, Jiun-Ting Yeh, Tseng-tong Kuo, Chih-Hsun Yang, Yung-Feng Lo, Kun-Ju Lin, Yung-Chang Lin, *John Wen-Cheng Chang. Prognostic Factors for Patients with Cutaneous Melanoma Undergoing Sentinel Lymph Node Biopsy in Taiwan. J Formos Med Assoc. 2013 Aug 19 [Epub ahead of print]
- Chiao-En Wu, Shin-Cheh Chen, Yung-Chang Lin, Yung-Feng Lo, Swei Hsueh, *Hsien-Kun Chang. Identification of Patients with Node-negative, Triple-negative Breast Cancer who Benefit from Adjuvant Cyclophosphamide, Methotrexate, and 5-Fluorouracil Chemotherapy. Anticancer Research. 2014, 34(3): 1301-6.
Full Publication List
Board Certification/Professional Affiliations:Taiwan Medical Association on 2008-04-21
Society of Internal Medicine, Republic of China on 2010-12-15
Medical Oncology of the Chinese Oncology Society on 2012-11